Indian digital healthcare company PharmEasy‘s parent firm API Holdings has pulled out IPO DRHP on Saturday. The company had filed an IPO DRHP with Securities and Exchange Board of India (SEBI) on November 9 last year, as per media reports.
The company will consider raising funds via rights issue, reported CNBC. API Holdings rights issue will have Compulsory Convertible Preference Shares (CCPS). The right issue will open in the first week of September this year.
API Holdings with subsidiaries like PharmEasy and Thyrocare provides health services ranging from radiology tests, teleconsultation, and home delivery of medical devices and products. The firm had acquired Thyrocare, India’s largest diagnostic test provider, earlier in 2021.
(With inputs from agencies)